Genesis

Person standing with their back turned while looking at a computer next while in a lab
AI biotech company Genesis scores $200M to advance drug discovery
By Jessica Hagen | 02:15 pm | August 22, 2023
The company will use the funds to bring its AI-enabled offerings into clinical development and advance its platform and portfolio.